Related Experiment Video
Updated: May 29, 2025

Multi-modal Pulmonary Imaging: Using Complementary Information from CT and Hyperpolarized 129Xe MRI to Evaluate Lung Structure-Function
Published on: April 12, 2024
Deep learning and machine learning in CT-based COPD diagnosis: Systematic review and meta-analysis
Qian Wu1, Hui Guo1, Ruihan Li1
1Department of Medical Imaging Center, The Fourth Clinical Medical College of Xinjiang Medical University, Urumqi, Xinjian 830000, China.
Background:
With advancements in medical technology and science, chronic obstructive pulmonary disease (COPD), one of the world's three major chronic diseases, has seen numerous remarkable outcomes when combined with artificial intelligence, particularly in disease diagnosis. However, the diagnostic performance of these AI models still lacks comprehensive evidence. Therefore, this study quantitatively analyzed the diagnostic performance of AI models in CT images of COPD patients, aiming to promote the development of related research in the future.
Methods:
PubMed, Cochrane Library, Web of Science, and Embase were retrieved up to September 1, 2024. The QUADAS-2 evaluation tool was used to assess the quality of the included studies. Meta-analysis of the included researches was performed using Stata18, RevMan 5.4, and Meta-Disc 1.4 software to merge sensitivity, specificity and plot a summary receiver operating characteristic curve (SROC). Heterogeneity was assessed using the Q statistic, and sources of inter-study heterogeneity were explored through meta-regression analysis.
Results:
Twenty-two of 3280 identified studies were eligible. Meta-analysis was performed on 15 of these studies, encompassing a total of 22,817 patients for which statistical metrics were reported or could be calculated. Seven studies were based on deep learning (DL) model, three on machine learning (ML) model, and five on DL model with multiple-instance learning (MIL) mechanisms. One study evaluated both DL and ML models. The meta-analysis results showed that the pooled sensitivity of all DL and ML models was 86 % (95 %CI 78-91 %), specificity was 87 % (95 %CI 83-91 %), and area under the curve was 93 % (95 %CI 90-95 %). Subgroup analyses revealed no significant difference in diagnostic sensitivity and specificity between DL and ML models (sensitivity 82 % (95 %CI 76-87 %), 93 % (95 %CI 85-97 %); specificity 87 % (95 %CI 79-91 %), 84 % (95 %CI 79-88 %), and the DL model with MIL (sensitivity 87 % (95 %CI 61-96 %); specificity 89 % (95 %CI 78-95 %) improved the performance of DL model, but this improvement was not statistically significant (p > 0.05).
Conclusion:
Both DL and ML models for diagnosing COPD using CT images exhibited high accuracy. There was no significant difference in diagnostic efficacy between the two types of AI models, and the addition of the MIL mechanism may enhance the performance of the DL model.
More Related Videos
08:05Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
07:53Author Spotlight: Advancing 3D Modeling for Enhanced Diagnosis and Treatment of Pulmonary Nodules in Early-Stage Lung Cancer
Published on: October 13, 2023
Related Concept Videos
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
COPD: Management Using Bronchodilators and Corticosteroids
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation